Related references
Note: Only part of the references are listed.CNKSR1 serves as a scaffold to activate an EGFR phosphatase via exclusive interaction with RhoB-GTP
Kanako Nishiyama et al.
LIFE SCIENCE ALLIANCE (2021)
Single-cell lineages reveal the rates, routes, and drivers of metastasis in cancer xenografts
Jeffrey J. Quinn et al.
SCIENCE (2021)
Sox9/INHBB axis-mediated crosstalk between the hepatoma and hepatic stellate cells promotes the metastasis of hepatocellular carcinoma
Yu Chen et al.
CANCER LETTERS (2021)
The In Vivo Selection Method in Breast Cancer Metastasis
Jun Nakayama et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Establishment and characterization of highly osteolytic luminal breast cancer cell lines by intracaudal arterial injection
Yuxuan Han et al.
GENES TO CELLS (2020)
Proliferative Classification of Intracranially Injected HER2-positive Breast Cancer Cell Lines
Yuka Kuroiwa et al.
CANCERS (2020)
A metastasis map of human cancer cell lines
Xin Jin et al.
NATURE (2020)
Proteoglycans as Mediators of Cancer Tissue Mechanics
Anna Barkovskaya et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
RUNX1 promotes tumour metastasis by activating the Wnt/β-catenin signalling pathway and EMT in colorectal cancer
Qingyuan Li et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Evaluating cell lines as models for metastatic breast cancer through integrative analysis of genomic data
Ke Liu et al.
NATURE COMMUNICATIONS (2019)
Metascape provides a biologist-oriented resource for the analysis of systems-level datasets
Yingyao Zhou et al.
NATURE COMMUNICATIONS (2019)
The Detection and Morphological Analysis of Circulating Tumor and Host Cells in Breast Cancer Xenograft Models
Loredana Cleris et al.
CELLS (2019)
Cullin-3/KCTD10 E3 complex is essential for Rac1 activation through RhoB degradation in human epidermal growth factor receptor 2-positive breast cancer cells
Akari Murakami et al.
CANCER SCIENCE (2019)
Loss of ABAT-Mediated GABAergic System Promotes Basal-Like Breast Cancer Progression by Activating Ca2+-NFAT1 Axis
Xingyu Chen et al.
THERANOSTICS (2019)
The emergence of trophoblast cell-surface antigen 2 (TROP-2) as a novel cancer target
David M. Goldenberg et al.
Oncotarget (2018)
A reliable murine model of bone metastasis by injecting cancer cells through caudal arteries
Takahiro Kuchimaru et al.
NATURE COMMUNICATIONS (2018)
Emerging role of RUNX3 in the regulation of tumor microenvironment
Sarala Manandhar et al.
BMB REPORTS (2018)
Comparative analysis of gene regulatory networks of highly metastatic breast cancer cells established by orthotopic transplantation and intra-circulation injection
Jun Nakayama et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma
Junhee Park et al.
ONCOTARGET (2017)
Impact of molecular subtypes on metastatic breast cancer patients: a SEER population-based study
Gong Yue et al.
SCIENTIFIC REPORTS (2017)
The emerging role of RUNX3 in cancer metastasis
Feifei Chen et al.
ONCOLOGY REPORTS (2016)
HER-2 Positive Breast Cancer - a Mini-Review
Hafiz Muhammad Asif et al.
Asian Pacific Journal of Cancer Prevention (2016)
Decreased expression of ABAT and STC2 hallmarks ER-positive inflammatory breast cancer and endocrine therapy resistance in advanced disease
Maurice P. H. M. Jansen et al.
MOLECULAR ONCOLOGY (2015)
Human epidermal growth factor receptor 2 positive (HER2+) metastatic breast cancer: how the latest results are improving therapeutic options
Hanfang Jiang et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2015)
Targeting Galectin-1 Overcomes Breast Cancer-Associated Immunosuppression and Prevents Metastatic Disease
Tomas Dalotto-Moreno et al.
CANCER RESEARCH (2013)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Targeting the function of the HER2 oncogene in human cancer therapeutics
M. M. Moasser
ONCOGENE (2007)
Novel clusters of highly expressed genes accompany genomic amplification in breast cancers
Emi Ito et al.
FEBS LETTERS (2007)
The transcription factor nuclear factor-kappa B and cancer
R. O. Escarcega et al.
CLINICAL ONCOLOGY (2007)
Decreasing the metastatic potential in cancers - Targeting the heparan sulfate proteoglycans
K Fjeldstad et al.
CURRENT DRUG TARGETS (2005)
Share Paper
